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Interactions between T  lymphocyte subsets characterize virtually all well-studied 
models of antigen-specific  immune suppression  (1-11).  In  addition,  soluble  factors 
possessing antigen-binding sites and I region-coded determinants have been found to 
play major roles in these cell-cell interactions (reviewed in  12,  13). However, no clear 
consensus has been reached as to the precise phenotype of each participating T  cell, 
the  total  number  of  cells  involved  in  the  overall  pathway  from  initial  antigen 
stimulation to actual suppression, or the importance of H-2 and/or variable region of 
immunoglobulin heavy chain (Vn) 1 -linked genetic restrictions at each step. At least 
some of the  difficulty  in  resolving  these  issues  arises  because most  studies  to  date 
appear to involve only a portion of a much larger sequence of cell interactions. 
Over the past several years these laboratories have attempted to explore these issues 
by analyzing the sequence of T-T interactions  in several T  suppressor  (Ts)  models. 
Previous  studies  have  defined  in  detail  the  production  of antigen-specific  T  cell- 
derived suppressor factors (TsF)  from antigen-induced  first-order Ts (Tsl)  (we have 
termed this TsF "TsFI") (14-17). In four different models, such TsF1 have been shown 
to bear I-J-subregion-coded determinants and to function by inducing a second set of 
Ts, termed Ys2, from resting T  cell populations  (2, 4,  17-21). This induction  occurs 
across H-2 and background genetic differences (19,  22, 23). More-recent studies have 
shown  that  these  TsF  share  serologically  detectable  idiotypic  determinants  with 
antibody of the same specificity (24, 25), and, in a model system involving suppression 
of delayed-type hypersensitivity (DTH) responses to the hapten azobenzenearsonate 
(ABA), that the Ts2 induced by idiotypic ABA-TsF1 are, in fact, anti-idiotypic  (10). 
The present study continues this work by investigating the suppressive activity of such 
anti-idiotypic  Ts2.  The  data  demonstrate  that  in  contrast  to  Tsl,  Ts2  are  able  to 
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suppress already immune animals. Furthermore, the Ts2  produce  a  second soluble 
factor, TsF2, which lacks Ig-constant-region determinants, bears H-2-coded determi- 
nants, is anti-idiotypic, and fails to act across H-2 genetic differences. These results 
provide the basis for a  hypothesis integrating a  number of suppressor models into a 
single overall scheme. 
Materials and Methods 
Mice.  A/J  (H-2  a, IgH-l~), A.By (H-2  b, Igh-l~), B10.A  (H-2  a, Igh-1 b) mice were obtained 
from The Jackson Laboratory, Bar Harbor, Maine. All animals in these experiments were 8-10 
wk of age at  the time of the experiment. All experimental groups consisted of at  least four 
animals per group. 
Preparation of Antigen andAntigen-coupled Cells.  These procedures have been described in detail 
elsewhere  (26). Briefly, a 40-mM solution of diazonium salt was prepared from p-arsanilic acid 
(Eastman  Kodak  Co.,  Rochester,  N.  Y.).  The  ABA  solution was  activated  as  previously 
described and conjugated to single-cell suspensions of erythrocyte-free spleen cells at a  final 
concentration of 10 mM ABA. After washing in Hank's balanced salts solution (HBSS), the 
ABA-coupled spleen cells  (ABA-SC)  were used to induce DTH or Ts. Trinitrophenyl (TNP)- 
coupled spleen cells were prepared as described earlier (27). 
Induction and Elicitation of DTH to ABA-  to  TNP-coupled Cells.  To induce DTH to ABA or 
TNP, a total of 3 ×  10 7  ABA-coupled syngeneic cells or TNP-coupled syngeneic spleen cells 
were injected subcutaneously into two separate sites on the dorsal flanks of mice. Challenge was 
performed four d later by injecting 30 #! of 10 mM diazonium salt ofp-arsanilic acid or 30 #1 
of  10  mM  2,4,6-trinitrobenzene sulfonic acid,  pH  7.4, (Eastman Kodak Co.)  into the  left 
footpad.  24  h  after  the  footpad  challenge, DTH  reactivity was  assessed  by measuring the 
swelling of the footpad using a Fowler Micrometer (Schlesinger's for Tools, Brooklyn, N. Y.). 
The magnitude of the DTH was expressed  as the increment of thickness of the challenged left 
footpad as compared with the untreated right footpad. Responses are given in units of 10  -2 mm 
+_ SEM. 
Induction of Suppressor Cells and Preparation of Suppressor Factors.  Normal A/J mice were injected 
intravenously  with 5 ×  107 ABA-SC. 7 d later, these mice served as donors of Tsl (10). Spleens 
from such animals were removed, and a single-cell suspension was prepared in HBSS. The cells 
were washed twice in HBSS and counted. To assay for the ability of such cells to inhibit ABA- 
specific  DTH, 5 ×  107 viable cells were injected intravenously into normal recipients, which 
were then primed subcutaneously with ABA-SC and challenged five d  later. Production of 
TsFx was done precisely as described earlier (17). Briefly,  1 ×  10s-5 ×  l0  s washed spleen cells 
in 1 ml of HBSS were subjected to alternate snap freezing at -78°C and thawing at 37°C. This 
was repeated four times and followed by centrifugation at  10,000 g for 90 rain. The supernates 
were adjusted to 5 X l0  s cell-equivalents/ml  and frozen until use at -40°C. To test the ability 
of TsFl to inhibit ABA-specific  DTH, the extract was injected intravenously into normal mice 
beginning  at the time of immunization  with 3 ×  107 ABA-SC. 2 ×  107 cell-equivalents  of factor 
were administered each day for five successive d, at which time the animals were challenged 
and their footpad responses  measured. To induce Ts2, TsFa  (2 ×  10  v cell-equivalents/d) was 
injected intravenously  into normal A/J mice for 5 successive d (10). On day 7, spleen cells were 
assayed for Ts2 activity by adoptive transfer to normal recipients, which were immunized and 
challenged as described above. TsF2 was prepared from the spleens of TsFl-treated animals in 
the same manner as TsFx. TsF2 was usually assayed by administering 2 ×  l0  T  cell-equivalents 
of extract/d per mouse on the day before and the day of footpad challenge of subcutaneously 
primed  mice.  As  indicated in Results,  however, Tsl, TsF1,  Ts2, and TsF2  were  also  tested 
according to other schedules to assess afferent versus efferent suppressive activity. 
Affinity  Chromatography of TsFz.  Solid-phase immunoadsorbent columns were prepared and 
characterized as described earlier (17, 25). Soluble TsF2 was fractionated on immunoadsorbents 
in the following manner. 5-ml plastic columns containing Sepharose 4B conjugated with the 
relevant protein were prepared and extensively washed with phosphate-buffered saline (PBS), 
pH 7.2, immediately before loading of the suppressor factors. The adsorption of the factor was 
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the gel matrix; the suppressor factor was then allowed to remain in the column for at least  60 
min at 4°C. The column was then washed with at least  five times its own void volume of PBS, 
pH 7.2. Such effluents were termed filtrates.  Materials that remained adsorbed to the column 
were rapidly eluted with five bed-volumes ofa glycine-HCl buffer, pH 2.8. The collected eluate 
was immediately neutralized  to pH  7.0 with  1 N  NaOH as the material  emerged from the 
column. Both the filtrate and the eluate were concentrated to the original volume by negative- 
pressure dialysis at 4°C and were thereafter frozen at -40°C. Such materials were thawed and 
adjusted to the appropriate concentration immediately before use. 
Purification of Suppressor Cells on Antigen-coated Plates.  Specific suppressor cells were separated 
according to a  modification of the method of Taniguchi and Miller  (28), as reported earlier 
(29). 
Antiserum Treatment.  Anti-Thy  1.2  hybridoma antiserum  was kindly provided by Dr.  P. 
Lake, University College, London, England. 1 ×  10  s spleen cells from animls treated with TsFl 
were incubated with  1 ml of 1:20 dilution of anti-Thy 1.2 hybridoma antibody for 45 min at 
0°C, washed once in HBSS, and then incubated again with 1 ml of a  1:10 dilution of Low-Tox 
rabbit  complement  (Cedarlane  Laboratories Ltd., London, Ontario,  Canada)  for 30 min at 
37°C. The cells were then washed twice in HBSS and passed over a Ficoll-Hypaque density 
gradient to remove the dead cells. The cells at the interface were recovered, extensively washed, 
counted  (>90%  viability  as  determined  by  trypan  blue  exclusion),  and  adjusted  to  the 
appropriate concentration for the preparation of TsF2. 
Statistical Analysis.  Analysis of the significance of the differences in the data obtained was 
carried out using a Wang programmable computer. The means and SEM were expressed as 
well as the relevant P value obtained with the two-tailed Student's t test. 
Results 
Tsl and Ts~ Differ in Their Ability to Suppress an Immunized Animal  Ts able to regulate 
the  response of an  immunized  animal  are  frequently  termed  "efferent"  suppressors 
and have been reported in several systems (30-32). This is in contrast to those Ts that 
act  only when  given before or at  the  time of initial  antigen  priming,  the  so-called 
"afferent" suppressors  (31).  Because Tsl arise before and stimulate Ts2, the ability of 
these two cell types to suppress when transferred  at different times during the ABA- 
DTH  response was investigated. Tsl and Ts2 cells were prepared as in Materials and 
Methods  and  transferred  to sets  of mice  that  were  primed  either  on  various  days 
before or on the day of Ts transfer.  All groups were challenged  in  the  footpad 4  d 
after priming, and the DTH  response assayed on day five. As shown in Fig.  1, both 
TSl and Ts2 suppress when given on the day of priming (afferent suppression). TSl fail 
to decrease  responses when  transferred  2  or more d  after priming.  Ts2,  in contrast, 
could suppress  the DTH  responses of mice when transferred  2 or 3  d  after priming, 
indicating  that  they  could  function  in  an  efferent  mode.  These  experiments  also 
clearly indicate that in addition to differential receptor specificity, as reported earlier 
(10), Tsl and Ts2 are functionally distinct suppressor T  cell subsets. 
The Tsz Capable of Suppressing  When Transferred Late in an Evolving Immune Response are 
Anti-Idiotypic.  In an earlier  report  (10)  the  Ts2 induced by TsFa were shown to be 
anti-idiotypic  by  the  demonstration  that  such  cells  adhered  to  plates  coated  with 
cross-reactive  major  idiotype  of A/J  anti-ABA  antibodies  (CRI)-eontaining  mouse 
immunoglobulin  (CRI-Ig). In that report, the anti-idiotypie cells were transferred  to 
mice at the time of immunization. To insure that the Ts2 that were able to act late in 
an ongoing immune response were the same anti-idiotypic Ts2 described earlier, plate- 
separated T  cells were transferred to immune mice 1 d  before challenge (Fig. 2). 
This experiment demonstrates that efferent suppressor cells were depleted from the 
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Fro.  1  Tsz  and Ts~ differ in  their ability  to suppress an  immunized animal.  A/J  mice were 
immunized with 3 X 107 ABA-SC subcutaneously on day 0.5 X 10  ~ Ts~ (~), induced by intravenous 
injection of ABA-SC, or Tss  (lk),  induced by TsF~, were transferred intravenously into different 
groups of mice either on the day of immunization (day 0) or day 2, or day 3, or day 4. All mice were 
challenged 4 d after immunization with 30/~1 of the diazonium salt ofp-arsanilic acid as described 
in Materials and Methods. 24 h later, the degree of footpad swelling was determined. The percentage 
of suppression transferred was calculated according to the following formula: 
•ffi  (positive control -- experimental value~ 
percent tolerance  \  positive control -  negative control  ]  X  100. 
* Not significantly different from control. 
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Fro.  2.  The Ts~ capable of suppressing when transferred late in an evolving immune response are 
anti-idiotypic. Ts2  were obtained  from A/J  mice treated with  2  X  107 cell-equivalents of TsF] 
(intravenously) for 5 successive d. They were then incubated first on rabbit anti-mouse Ig plates to 
remove the immunoglobulin-bearing B cells. Part of the enriched T  cell population was assayed for 
suppressor activity (group C) or subjected to further purification on plates coated either with normal 
A/J  immunoglobulin  (groups  D  and  E)  or  anti-ABA  antibodies containing CRI  determinants 
(groups F and G). The various l~pulations were transferred to different groups of A/J mice which 
had been immunized with 3 X 10  ABA-SC 3 d earlier to assay for efferent suppression. All the mice 
and the appropriate control animals were challenged with the diazonium salt 24 h after cell transfer 
and increase in footpad swelling was determined 24 h after challenge. The bars represent the mean 
footpad swelling of at least four mice/group. 454  H-2-RESTRICTED  EFFERENT SUPPRESSION 
Ig-coated  plates.  In  addition,  such  cells were  recovered  only  from  CRI-Ig-coated 
plates. Therefore,  the Ts2  capable of inhibiting an  ongoing  immune  response have 
anti-idiotypic receptors. 
Ts2  and  a  Soluble Suppressor Factor (TsF2)  Derived from  Ts~  Suppress  Fully  Immune 
Mice.  The preceding experiments, although demonstrating the ability of Ts2 to act 
late after priming, did not prove that such Ts could inhibit the elicitation of DTH  in 
a  fully immune animal already able to give a  response at the time of Ts transfer. The 
inability of Ts2 to suppress when given on the day ofchaUenge (Fig. 1) might indicate 
either that  these cells cannot  inhibit  fully differentiated primed T  cells or, alterna- 
tively, that additional time is necessary for optimal Ts2 activity after transfer, either 
alone or in concert with additional cells of the recipient. To explore these issues, and 
to determine if Ts2 acted via a  soluble factor in analogy to Tsl and TsF1, a  series of 
experiments was carried out  in which challenge was delayed until day 5, permitting 
Ts2 or TsF2 transfer beginning on day 4, a time at which DTH can be readily elicited. 
As shown  in  Fig.  3,  either Ts2,  administered on  day 4,  or a  soluble extract  of Ts2, 
termed  TsF2,  given  on  days  4  and  5,  markedly  inhibited  ABA  DTH  responses, 
indicating their ability to suppress the activity of already immune cells. Further, the 
source of TsF2 is shown to be a T  cell by the loss of TsF2 activity from an anti-Thy 1.2 
plus C-treated cell population. 
Suppression by TsFz is Antigen Specific.  In an earlier report, it was shown  that TsF1 
acted in an antigen-specific fashion (17). Because antigen-specific suppressor pathways 
may terminate with a  nonspecific effector molecule (33-34), the antigen specificity of 
the TsF2 was  tested.  The  results in  Fig. 4  show  that  TsF2 was  not  able to suppress 
DTH  to the hapten TNP.  Hence, TsF2 functions in an antigen-specific fashion. 
Functional Characterization of TsFz.  To further analyze the activity of TsF~, a  series 
of functional  experiments comparing it  to TsF1 was  carried out.  In  the experiment 
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Fie. 3.  Ts2 and a soluble suppressor factor TsF~ derived from Tsa suppress fully immune mice. Ts2 
were obtained from A/J mice as described in Materials and Methods. Some of the Ts2 were assayed 
for suppressor activity by adoptive transfer (group B), whereas others were either not treated (group 
C) or treated with complement  alone as control  (group  D)  or with  anti-Thy  1.2 antibody and 
complement  (group  E).  After  the antiserum  treatment, viable cells were recovered by density 
gradient separation using Ficoll-Hypaque. These cells (groups C, D, and E) were then subjected to 
several freeze-thaws to produce  TsF2 as described in Materials  and Methods. To assay for TsF2 
activity, A/J mice were immunized  with  3 ×  107 ABA-SC on day 0. On day 4 or 5, they were 
treated with 3 ×  107 cell equivalents of TsF2 (intravenously) for two successive d. All the animals 
and the appropriate controls were challenged on day 5 and the increased footpad swelling measured 
24 h later. The bars represent the mean footpad swelling of at least four mice/group. DIETZ, SY,  BENACERRAF, NISONOFF, GREENE, AND GERMAIN  455 
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Fro,  4.  TsF2 is antigen specific. A/J mice were immunized with tither 3 X  ]0  7 ABA-SC or 3 X  ]0  7 
TNP-SC subcutaneously on day 0. On days 3 and 4, they received 3 X  10  7 cell equivalents of TsF2 
obtained from animals injected with ABA-specific  TsFl (groups B and E). All the animals and the 
appropriate controls were challenged on day 4 with the diazonium salt ofp-arsanillc acid or TNBS 
in the footpad. 24 h later, the degree of footpad swelling was determined. The bars represent the 
mean footpad swelling  of at least four mice/group. 
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Fro.  5.  In contrast to TsF1, which suppresses the afferent limb, TsF2 suppresses the efferent limb 
of the immune response, l0  s cell-equivalents  of TsFl or TsF2 were administered intravenously into 
different groups of A/J mice over 5-d periods (day 0 to day 4), beginning on the day of immunization 
with 3 ×  107 ABA-SC (subcutaneously)  (groups B and C), or only on the day before and the day of 
footpad challenge (days 3 and 4) (groups D and E). The mice were challenged with the diazonium 
salt on day 4. 24 h later, the degree of footpad swelling  was determined. 
depicted  in  Fig.  5,  TsFt  and  TsF2  were  each  administered  to  different  sets  of 
immunized A/J  mice. They were either given over 5  d, beginning with the day of 
immunization and ending with the day of challenge, or they were administered only 
on the  day before and the day of challenge. TsFI was  able to  suppress only when 
administered beginning with  the  day of immunization. TsF2 was  able to  suppress 
when administered in either fashion. This pattern paralleled that seen with the cells, 
i.e., TsF1 acts only in the afferent mode, whereas TsF2 can act in the efferent mode. 
A  characteristic feature of TsF1 studied in these laboratories is activity across H-2 
differences.  This  contrasts  markedly  with  data  on  antigen-specific TsF  active  in 
secondary humoral responses as reported by Tada et al. (35), and recent work showing 
that 4-hydroxy-3-nitrophenyl  acetyl (NP)-specific efferent Ts failed to suppress across 
I-region differences  (37).  TsF2 was  thus  tested  for  its  ability to  act  across  various 
genetic differences. Fig. 6 shows that TsF1 from A/J mice was able to suppress DTH 
in the H-2-congenic strain A.BY (H-2b). On the other hand, TsF2, produced from Ts2 
induced  by  the  same  lot  of TsFt,  was  unable to  suppress  the  A.By  strain  when 456  H-2-RESTRICTED  EFFERENT  SUPPRESSION 
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FIc.  6.  H-2 restriction of ABA-TsF2 activity. A total of l0  s cell-equivalents of A/J-derived TsFl or 
6  X  107 cell-equivalents of TsF~ was administered on days 0-4 or 4 and 5 to A/J and A.BY mice, 
respectively. These mice were all  immunized with ABA-syngeneic spleen cells subcutaneously on 
day 0 and challenged in the footpad with diazonium salt on day 5. Footpad swelling was determined 
24 h  later. 
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FIG.  7.  Influence of H-2 and non-H-2 genes on the activity of ABA-TsF2.  ABA-TsF2  was prepared 
as described in Materials and Methods from A/J, A.BY, and BI0.A mice. 6  ×  107 cell-equivalents 
of the indicated TsF2 preparation was administered on days 3 and 4 to mice primed subcutaneously 
on day 0 with ABA-syngeneic spleen cells. On day 4, mice were challenged with diazonium salt in 
the footpad, and swelling determined 24 h later. 
administered in the efferent mode. Thus, TsF2, in contrast to TsF1, cannot act across 
H-2 differences. 
Additional experiments were then carried out to assess whether or not gene products 
of non-H-2  loci also played a  role in  restricting TsF2  activity. Furthermore,  it was 
important to insure that the inability of the A.By mice to be suppressed in the efferent 
mode by A/J TsF2 was not because of some inherent defect in TsF2 activity in A.By 
mice. Therefore, in the experiment depicted in Fig. 7, TsFz was produced not only in DIETZ,  SY,  BENACERRAF, NISONOFF, GREENE, AND GERMAIN  457 
A/J, but also in the H-2-congenic strain A.By and in B10.A, which, like A/J, is H-2  a 
but which  differs  in its background. The TsF2 was  produced  in each  of the  three 
strains by administration of TsF1 derived from the same strain. A/J-derived TsF2 was 
only able to suppress the immune response in A/J mice. A.By and B10.A mice were 
nonetheless suppressed by syngeneic TsF2. Thus, both H-2 and non-H-2 gene products 
play roles in genetically restricting the function of TsF2. 
Immunochemical  Characterization  of TsF2.  A/J  TsFl  has  been shown  to  bear  H-2- 
coded  determinants, but  no Ig constant region determinants (17,  25).  In addition, 
TsFa binds to ABA-conjugated Sepharose 4B columns and is retained by an anti-CRI 
column. TsF2 was  similarly characterized  immunochemically in a  series  of experi- 
ments, the results of which are shown in Table I.  In these studies, the filtrates and 
acid eluates of TsF2 passed over a  variety of immunoadsorbents were  tested in the 
efferent mode. TsF2 from A/J (H-2  a) mice was retained by an anti-H-2  ~ column, but 
not an anti-H-2  q or by an anti-mouse Ig column. The activity retained on the anti-H- 
2  ~ absorbent could be recovered in the acid eluate. Furthermore, TsF2 was retained 
by and eluted from a  column to which CRI-Ig was coupled, but not to columns to 
which nonspecific immune A/J  Ig was coupled nor to columns to which ABA was 
ThaLe  I 
Immunochemical Characterization of ABA- TsF2 
Percent 
Experi-  Immunoadsorbent fraction*  Footpad size:]:  suppres- 
ment  sion§ 
X  10 -2ram ± SEM 
1  None (positive  control)  25.2 ± 2.0  -- 
RAMIg, filtrate  11.3 ±  1.1 (P < 0.01)  79 
RAMIg, eluate  29.8 ±  1.8 (NS)  0 
B10 anti-B10.A, filtrate  21.8 ± 2.1 (NS)  20 
B10 anti-Bl0.A, eluate  14.0 ±  1.5 (P< 0.01)  64 
None (positive  control)  23.2 ± 2  -- 
Unfractionated ABA-TsF2  5,0 ±  1.1 (P < 0,00l)  100 
BI0 anti-Bl0.A, filtrate  18.7 + 0.9 (NS)  21 
BI0 anti-Bl0.A, eluate  7.5 ± 0.2 (P < 0.001)  80 
(BI0.D2 × B10.BR) anti-Bl0.6R, filtrate  5.5 ± 0.8 (P< 0.001)  86 
(BI0.D2 × B10.BR) anti-B10.6R, eluate  23.0 + 2.4 (NS)  0 
None (positive  control) 
Unfractionated ABA-TsF2 
A/J control Ig (CRI-), filtrate 
A/J control Ig (CRI-), eluate 
A/J anti-ABA Ig (CRI+), filtrate 
A/J anti-ABA Ig (CRI+), eluate 
ABA-FTG, filtrate 
ABA-F-/G,  eluate 
29.3 ± 3.0 
7.8:1:1.2 (P< 0.01)  100 
9.0 ± 0.9 (P< 0.01)  100 
30.5 ± 3.4 (NS)  0 
25.0:1:1.4 (NS)  22 
16.5 ± .9 (P< 0.01)  65 
13.8:1:2.3 (P< 0.07)  79 
28.3 ±  1.7 (NS)  0 
RAMIg, rabbit anti-mouse Ig; FyG, fowl gamma globulin. 
* A/J ABA-TsF2  was passed over indicated immunoadsorbent and filtrate, then acid eluate collected, and 
tested in the efferent mode. BI0 anti-Bl0.A ffi antibH-2  ~, (B10.D2 ×  BI0.BR); anti-B10.6R ffi anti-H- 
2Kq,I  q. 
:~ P value is in comparison to positive control. 
re  "  {  positive control DTH -  experimental DTH  § percent supp  sslon  ffi /  /  ×  100%. 
\positive control DTH -  negative control DTH] 458  H-2-RESTRICTED  EFFERENT  SUPPRESSION 
coupled  in  the  form of ABA-fowl gamma globulin.  These experiments characterize 
TsFz as having H-2 determinants and anti-idiotypic specificity. It does not have anti- 
antigen binding activity. 
Discussion 
The studies reported above provide significant  new information about the T  cells 
and T  cell-derived products involved in antigen-specific immune suppression of ABA 
DTH (10,  17, 25,  26, 29).  The data indicate that antigen-specific Tsl and TsF1 act in 
the afferent mode, before immunization, whereas Ts2 and the soluble product of these 
anti-idiotypic  cells,  TsF2,  act  in  the  efferent  mode in  fully  immune  animals.  TsF2 
from the A/J strain has been characterized functionally and immunochemically. In 
contrast to TsFI, TsF2 fails to act across either H-2 or non-H-2 genetic differences, as 
shown by the observations that TsF2 from A/.J mice was not suppressive in A.By or 
B10.A  mice.  The  active material  lacks  Ig constant  region  determinants  and  ABA- 
binding activity, but possesses H-2-coded determinants and has anti-idiotypic  (anti- 
CRI)  binding specificity. Similar idiotypic and anti-idiotypic TsF that suppress the 
idiotypic component of the humoral anti-ABA response have been reported previously 
(36). 
Two major issues are  raised  by these  results.  The first  involves the  difference in 
mode of action  between  TsFa  and  TsF2.  Several earlier studies  have demonstrated 
that some Ts act only in nonimmune animals to prevent priming, whereas other Ts 
can inhibit responses of immune animals (31,  37).  The present report confirms these 
observations, in a  model in which the direct relationship between the two cell types 
has been established.  It is not clear if Tsl have any actual suppressive activity, or if 
they function  only via Ts2 induction.  The time (24-48  h)  needed  for this inductive 
step would account for the inability of Tsl to function late in the immune response. 
Ts2 clearly act in primed animals, but whether or not Ts2 are actually effector Ts is 
not  apparent. Their failure to suppress when given on the day of challenge may be 
simply a quantitative or homing problem, or may, in fact, reflect the necessity for Ts2 
to act on a third cell type which might be the actual effector suppressor cell. Whether 
or not  the  target of Ts2 activity is another cell  in  the suppressor pathway or is  the 
immune cell  being suppressed,  the specificity of action  shown  by the anti-idiotypic 
Ts2 and the previous demonstration of the failure of such cells to suppress mice lacking 
the appropriate allotype linkage group of genes necessary for CRI expression indicate 
that the target cell bears idiotypic (CRI) determinants.  Recent experiments have in 
fact identified a  CRI  + T  cell distinct  from the DTH effector cell that is required  for 
Ts2-mediated suppression (M.-S. Sy, unpublished observations). 
The second major issue raised by this study involves the genetic restrictions evident 
in TsF2, but  not TsF~ activity.  Examining TsF obtained from Ts in  the L-glutamic 
acid6°-L-alaninea°-L-tyrosine  ~°,  L-glutamic  acidS°-L-tyrosine  5°,  or  ABA  (M.-S.  Sy, 
manuscript in preparation) models (19, 20) has not revealed the I-J restrictions of TsF 
function reported by Tada et al. (35). In each of these cases, TsF1 activity across I-I-2 
differences is quantitatively  and qualitatively undistinguishable  from that observed 
in H-2-identical animals. The finding that ABA-TsF2 fails to act in H-2-different mice 
suggests  strongly  that  one  explanation  for the  apparent  discrepancy  in  the  earlier 
studies  is that  the TsF studied  by Tada et al.  (35)  is a  TsF2 and not TsF1, and that 
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prolonged (4 wk) time period used to generate the keyhole limpet hemocyanin-specific 
Ts  (38)  and the ability of these cells to suppress primed T  cell populations  (39). It 
may  be  relevant  that  the  suppressor  cells  identified  by  Owen  et  al.  (40)  after 
hyperimmunization and a prolonged rest period were anti-idiotypic in their specificity. 
We have recently proposed (41)  an overall pathway of T  cell-TsF activity based on 
this analysis that  integrates the major features of several reported Ts models into a 
single  scheme.  In  this  model,  antigen-specific,  H-2-unrestricted  TsFa  induces  Ts2, 
which  produces  TsF2.  This  material  in  turn  acts  in  an  H-2-restricted  manner  on 
antigen-primed idiotypic auxiliary Ts (Ts3; Taux) that mediate effector suppression. 
Other groups have also demonstrated a  role for H-2 gene products in Ts activity. 
Thus,  Miller et al.  (42)  have shown  that  suppression  requires identity between Ts 
donor  and  recipient  at  the  H-2D  locus  in  the  dinitrophenyl-coupled  cell  model. 
Weinberger  et  al.  (37)  showed  that  NP-specific  Ts2  failed  to  act  across  I-region 
differences. Epstein and Cohn  (43), exploring alloinduced Ts, and Jandinski  et al. 
(44), studying TNP-modified, self-induced Ts active in humoral immune responses, 
observed H-2-restricted suppressor function.  Rich  and  Rich  (45)  showed  that  TsF 
active  in  inhibiting  mixed  lymphocyte responses  required  I-C  subregion  identity 
between  producer  and  acceptor  (45).  Moorehead  (46,  47)  found  that  dinitroben- 
zenesulfonate (DNBS)-induced TsF was also H-2K- or H-2-D-restricted in its inter- 
action with its target cell. Recently, Yamuchi et al. 2 have found a sheep erythrocyte- 
specific TsF in the feedback suppression model which shows H-2 restriction. Thus, 
such H-2 genetic restrictions are common in suppressor systems, although the subre- 
gion involved appears to differ in the various examples, and the site in the pathway 
at which the genetic influence exists has not always been evaluated. In all of these 
studies, it is not yet clear if the restriction reflects the receptor specificity of the TsF 
itself, as is true of H-2-restricted cytoxic lymphocytes, the receptor specificity of the 
target cell, or some other interaction process controlled by H-2-1inked genes. 
A final point concerns the influence of background genes on TsF2 activity. Several 
groups have demonstrated  a  role for non-H-2-, non-Vn-linked  genes in Ts activity 
(48, 49). More recently, Weinberger et al.  (37)  and Eardley et al.  (50)  have reported 
on the critical role of VH-linked genes in T-T interaction in Ts pathways. Based on 
the known anti-idiotypic specificity of TsF2, and the finding that Ts2 fail to act across 
allotype differences in congeneic strains of mice (50), it is most likely that the influence 
of non-H-2  genes  on  TsFz  activity  in  the  ABA  model  reflects  a  requirement  for 
idiotype expression in the recipient to serve as the TsF2 target. Thus, mapping studies 
currently in  progress might  be expected to reveal that  the relevant non-H-2 genes 
controlling TsF2  function are  allotype-linked (Vn)  genes.  It should be pointed out 
that the requirement for idiotype expression to permit detection of Ts2 activity can 
lead to detection of pseudorestrictions of TsF1 activity. Sy et al.  (51)  have recently 
demonstrated  that  the  apparent  failure  of ABA-TsF1  (M.-S.  Sy,  manuscript  in 
preparation) or CRI-coupled spleen cells to suppress CRI- mice is not a  result of a 
failure of Ts2 induction by these materials because of VH restrictions, but rather, of a 
failure of Ts activity because of the absence of an idiotypic target in these animals. 
Thus, the apparent VH restriction of TsF1 activity under such circumstances does not 
truly reflect the activity of the TsF itself but rather reflects genetic constraints on later 
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parts of the suppressor pathway. These findings must be kept in mind in evaluating 
any apparent restrictions of Ts interactions. 
These  experiments  have  extended  our  knowledge  about  the  cells  and  factors 
involved in a single Ts model and pointed out the similarities and differences involved 
in T-T interactions in two successive stages of the ABA suppressor pathway. These 
observations  have also  been of help  in  understanding  the  relationship  among  the 
various suppressor systems in the literature. Future studies may reveal the basis for 
initiation  of the  suppressor pathway and  the  actual  means  by which  Ts decrease 
immune responses. 
Summary 
Azobenzenearsonate  (ABA)-specific T  cell-derived suppressor factor (TsF1)  from 
A/J  mice was used to induce second-order suppressor T  cells  (Ts2).  Comparison of 
suppressor T  cells induced by antigen (Tsl) with Ts2 induced by TsFx revealed that 
Ts~ were afferent suppressors active only when given at the time of antigen priming, 
and  not  thereafter, whereas Ts2 could act when transferred at any time up to  1 d 
before antigen challenge for a  delayed-type hypersentivity response. This was  true 
even when the recipient could be shown to be fully immune before transfer of Ts2, 
thus defining these cells as efferent suppressors. The anti-idiotypie specificity of the 
Ts2 was demonstrated by the ability of Ts2 to bind to idiotype (cross-reactive idiotype 
[CRI])-coated Petri  dishes.  A  soluble extract from Ts2  (TsF~)  was  also  capable  of 
mediating efferent suppression that was functionally antigen-  (ABA) specific. Com- 
parison of TsF1 with this new factor, TsF2, revealed that both lack Ig-constant-region 
determinants,  possess  H-2-coded determinants,  and show specific binding  (to ABA 
and to CRI+-Ig, respectively). TsFx acts in strains that differ with respect to H-2 and 
background genes, whereas TsF2 shows H-2- and non-H-2-1inked genetic restrictions. 
This existence of H-2 restriction of TsF2 activity suggests that the apparent discrep- 
ancies in  studies  on  H-2 restriction of TsF may be a  result of the analysis of two 
separate classes of TsF, only one of which shows genetically restricted activity, thus 
unifying several models of suppressor cell activity. 
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